journal article·2022-01-18Open access

Theranostic potential of self-luminescent branched polyethyleneimine-coated superparamagnetic iron oxide nanoparticles

Rouhollah Khodadust, Ozlem Unal, Havva Yagci Acar

Abstract

Polyethylenimine (PEI), which is frequently used for polyplex formation and effective gene transfection, is rarely recognized as a luminescent polymer. Therefore, it is usually tagged with an organic fluorophore to be optically tracked. Recently, we developed branched PEI (bPEI) superparamagnetic iron oxide nanoparticles (SPION@bPEI) with blue luminescence 1200 times stronger than that of bPEI without a traditional fluorophore, due to partial PEI oxidation during the synthesis. Here, we demonstrate in vitro dye-free optical imaging and successful gene transfection with luminescent SPION@bPEI, which was further modified for receptor-mediated delivery of the cargo selectively to cancer cell lines overexpressing the epidermal growth factor receptor (EGFR). Pro-apoptotic polyinosinic–polycytidylic acid sodium (PIC) was delivered to HeLa cells with SPION@bPEI and caused a dramatic reduction in the cell viability at otherwise non-toxic nanoparticle concentrations, proving that bPEI coating is still an effective component for the delivery of an anionic cargo. Besides, a strong intracellular optical signal supports the optically traceable nature of these nanoparticles. SPION@bPEI nanoparticles were further conjugated with Erbitux (Erb), which is an anti-EGFR antibody for targeting EGFR-overexpressing cancer cell lines. SPION@bPEI-Erb was used for the delivery of a GFP plasmid wherein the transfection was confirmed by the luminescence of the expressed gene within the transfected cells. Poor GFP expression in MCF7, a slightly better expression in HeLa, and a significant enhancement in the transfection of HCT116 cells proved a selective uptake and hence the targeting ability of Erb-tagged nanoparticles. Altogether, this study proves luminescent, cationic, and small SPION@bPEI nanoparticles as strong candidates for imaging and gene therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (69)

Show source-provided references
1. 10.1039/c2nr31002c10.1039/c2nr31002c ↗
2. 10.1039/c3nr02286b10.1039/c3nr02286b ↗
3. 10.1039/c3tb21760d10.1039/c3tb21760d ↗
4. 10.1039/c4tb00291a10.1039/c4tb00291a ↗
5. 10.1039/c6tb01468b10.1039/c6tb01468b ↗
6. 10.1021/cm202159310.1021/cm2021593 ↗
7. 10.1021/cm010291q10.1021/cm010291q ↗
8. 10.1016/j.bbagen.2010.05.00310.1016/j.bbagen.2010.05.003 ↗
9. 10.1146/annurev.biochem.67.1.50910.1146/annurev.biochem.67.1.509 ↗
10. 10.1126/science.110427410.1126/science.1104274 ↗
11. 10.1016/j.progpolymsci.2013.09.00510.1016/j.progpolymsci.2013.09.005 ↗
12. 10.1002/(sici)1521-3773(19980302)37:4<402::aid-anie402>3.0.co;2-910.1002/(sici)1521-3773(19980302)37:4<402::aid-anie402>3.0.co;2-9 ↗
13. 10.1039/b9nr00374f10.1039/b9nr00374f ↗
14. 10.1039/c3cs60036j10.1039/c3cs60036j ↗
15. 10.1246/cl.13087710.1246/cl.130877 ↗
16. 10.1039/c4cc02880e10.1039/c4cc02880e ↗
17. 10.1038/srep0276310.1038/srep02763 ↗
18. 10.1002/marc.20070019010.1002/marc.200700190 ↗
19. 10.1038/srep0303610.1038/srep03036 ↗
20. 10.1002/marc.20080057110.1002/marc.200800571 ↗
21. 10.1021/ja047591410.1021/ja0475914 ↗
22. 10.1002/chem.20110062010.1002/chem.201100620 ↗
23. 10.1021/ja045499210.1021/ja0454992 ↗
24. 10.1016/j.jcis.2006.10.02510.1016/j.jcis.2006.10.025 ↗
25. 10.1016/j.ejpb.2004.11.01110.1016/j.ejpb.2004.11.011 ↗
26. 10.1016/j.nano.2008.12.00710.1016/j.nano.2008.12.007 ↗
27. 10.1039/c002775h10.1039/c002775h ↗
28. 10.1016/j.jconrel.2011.03.02010.1016/j.jconrel.2011.03.020 ↗
29. 10.1038/mt.2010.23310.1038/mt.2010.233 ↗
30. 10.1016/s0168-3659(99)00090-510.1016/s0168-3659(99)00090-5 ↗
31. 10.1039/c2cc33472k10.1039/c2cc33472k ↗
32. 10.1039/c1sc00064k10.1039/c1sc00064k ↗
33. 10.1021/jp100312e10.1021/jp100312e ↗
34. 10.1016/j.colsurfb.2015.05.05110.1016/j.colsurfb.2015.05.051 ↗
35. 10.1002/macp.20170056310.1002/macp.201700563 ↗
36. 10.2217/nnm.16.510.2217/nnm.16.5 ↗
37. 10.1002/ange.20160904310.1002/ange.201609043 ↗
38. 10.1016/j.jconrel.2014.05.00610.1016/j.jconrel.2014.05.006 ↗
39. 10.1007/s12274-009-9035-610.1007/s12274-009-9035-6 ↗
40. 10.1002/adhm.20150056310.1002/adhm.201500563 ↗
41. 10.1002/adfm.20080076510.1002/adfm.200800765 ↗
42. 10.1038/sj.mt.630023310.1038/sj.mt.6300233 ↗
43. 10.2174/13892011079224651910.2174/138920110792246519 ↗
44. 10.1021/nn700344x10.1021/nn700344x ↗
45. 10.1021/ja710312510.1021/ja7103125 ↗
46. 10.1016/j.biomaterials.2014.01.04110.1016/j.biomaterials.2014.01.041 ↗
47. 10.1021/acsami.5b0402210.1021/acsami.5b04022 ↗
48. 10.1039/c4tb01273a10.1039/c4tb01273a ↗
49. 10.1016/j.jconrel.2006.02.00910.1016/j.jconrel.2006.02.009 ↗
50. 10.1080/20022727.2018.148849710.1080/20022727.2018.1488497 ↗
51. 10.1016/j.actbio.2015.07.02010.1016/j.actbio.2015.07.020 ↗
52. 10.1016/j.ultramic.2017.07.00110.1016/j.ultramic.2017.07.001 ↗
53. 10.1039/c5nr00189g10.1039/c5nr00189g ↗
54. 10.1021/bm400462810.1021/bm4004628 ↗
55. Kumar · 2007 · 10
56. 10.1016/j.ymthe.2005.02.01010.1016/j.ymthe.2005.02.010 ↗
57. 10.1039/c000190b10.1039/c000190b ↗
58. Uwem Okon · Int. J. Innovation Appl. Stud. · 2014 · 5 · 192
59. 10.1021/jp045402y10.1021/jp045402y ↗
60. 10.1016/j.jallcom.2012.05.05310.1016/j.jallcom.2012.05.053 ↗
61. 10.1016/j.tiv.2017.02.00710.1016/j.tiv.2017.02.007 ↗
62. 10.1016/j.biomaterials.2008.04.03610.1016/j.biomaterials.2008.04.036 ↗
63. 10.1155/2015/39756310.1155/2015/397563 ↗
64. 10.1016/j.jconrel.2009.02.00310.1016/j.jconrel.2009.02.003 ↗
65. 10.1016/j.jconrel.2009.06.03110.1016/j.jconrel.2009.06.031 ↗
66. 10.1158/1078-0432.ccr-16-000410.1158/1078-0432.ccr-16-0004 ↗
67. 10.1186/1756-0500-4-14010.1186/1756-0500-4-140 ↗
68. 10.1021/acs.analchem.5b0257210.1021/acs.analchem.5b02572 ↗
69. 10.3892/or.2017.602510.3892/or.2017.6025 ↗